The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype

International Journal for Parasitology

Volumn 43, Issue 3-4, 2013, Pages 211-223

  Rzepecka, Justyna ^a   Siebeke, Ivonne ^a   Coltherd, Jennifer C ^b   Kean, Dorothy E ^b   Steiger, Christina N ^b   Al Riyami, Lamyaa ^a   McSharry, Charles ^b   Harnett, Margaret M ^b   Harnett, William ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Airway inflammation; Asthma; ES 62; IFN ; IL 17; IL 4; Neutrophil; Parasitic helminth

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GLYCOPROTEIN; GLYCOPROTEIN ES 62; IMMUNOGLOBULIN E; INTERLEUKIN 17; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ENDOPARASITE; EXPERIMENTAL STUDY; PATHOLOGY; PHENOTYPE; RODENT; STEROID;

ACANTHOCHEILONEMA VITEAE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; HELPER CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; TH1 TH2 BALANCE; TH17 CELL; TH2 CELL;

ANIMALS; FEMALE; HELMINTH PROTEINS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED BALB C; PROTECTIVE AGENTS; RESPIRATORY HYPERSENSITIVITY; TH1 CELLS; TH17 CELLS; TH2 CELLS;

ACANTHOCHEILONEMA VITEAE; VERMES;

EID: 84873737527     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.12.001     Document Type: Article

References (66)

1. Adams C.L., Grierson A.M., Mowat A.M., Harnett M.M., Garside P. Differences in the kinetics, amplitude, and localization of ERK activation in anergy and priming revealed at the level of individual primary T cells by laser scanning cytometry. J. Immunol. 2004, 173:1579-1586.
2. Anderson P.O., Manzo B.A., Sundstedt A., Minaee S., Symonds A., Khalid S., Rodriguez-Cabezas M.E., Nicolson K., Li S., Wraith D.C., Wang P. Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. Eur. J. Immunol. 2006, 36:1374-1385.
3. Barczyk A., Pierzchala W., Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 2003, 97:726-733.
4. Barin J.G., Baldeviano G.C., Talor M.V., Wu L., Ong S., Quader F., Chen P., Zheng D., Caturegli P., Rose N.R., Cihakova D. Macrophages participate in IL-17-mediated inflammation. Eur. J. Immunol. 2012, 42:726-736.
5. Bosse Y., Thompson C., Stankova J., Rola-Pleszczynski M. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 2006, 34:746-753.
6. Bossie A., Brooks K.H., Krammer P.H., Vitetta E.S. Activation of murine B cells from different tissues with different mitogens. II. Isotype distribution of secreted immunoglobulins in the presence and absence of IL-4-containing T cell supernatants. J. Mol. Cell. Immunol. 1987, 3:221-226.
7. Busse W.W., Lemanske R.F. Asthma. N. Engl. J. Med. 2001, 344:350-362.
8. Busse W., Neaville W. Anti-immunoglobulin E for the treatment of allergic disease. Curr. Opin. Allergy Clin. Immunol. 2001, 1:105-108.
9. Carter R.J., Bradding P. The role of mast cells in the structural alterations of the airways as a potential mechanism in the pathogenesis of severe asthma. Curr. Pharm. Des. 2011, 17:685-698.
10. Chen L., Grabowski K.A., Xin J.P., Coleman J., Huang Z., Espiritu B., Alkan S., Xie H.B., Zhu Y., White F.A., Clancy J., Huang H. IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils. J. Immunol. 2004, 172:2059-2066.
11. Cobbold S.P. The hidden truth about gene expression in Tregs: is it what you don't see that counts?. Eur. J. Immunol. 2006, 36:1360-1363.
12. Dias P.M., Banerjee G. The role of Th17/IL-17 on eosinophilic inflammation. J. Autoimmun. 2012, (E-pub ahead of print).
13. Durrant D.M., Gaffen S.L., Riesenfeld E.P., Irvin C.G., Metzger D.W. Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J. Immunol. 2009, 183:5293-5300.
14. Durrant D.M., Metzger D.W. Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol. Invest. 2010, 39:526-549.
15. Feltis B.N., Wignarajah D., Zheng L., Ward C., Reid D., Harding R., Walters E.H. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am. J. Respir. Crit. Care Med. 2006, 173:1201-1207.
16. Finotto S., Neurath M.F., Glickman J.N., Qin S., Lehr H.A., Green F.H., Ackerman K., Haley K., Galle P.R., Szabo S.J., Drazen J.M., De Sanctis G.T., Glimcher L.H. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science (New York, NY) 2002, 295:336-338.
17. Fujiwara M., Hirose K., Kagami S., Takatori H., Wakashin H., Tamachi T., Watanabe N., Saito Y., Iwamoto I., Nakajima H. T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J. Allergy Clin. Immunol. 2007, 119:662-670.
18. Gilfillan A.M., Beaven M.A. Regulation of mast cell responses in health and disease. Crit. Rev. Immunol. 2011, 31:475-529.
19. Goodridge H.S., Wilson E.H., Harnett W., Campbell C.C., Harnett M.M., Liew F.Y. Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J. Immunol. 2001, 167:940-945.
20. Goodridge H.S., Marshall F.A., Wilson E.H., Houston K.M., Liew F.Y., Harnett M.M., Harnett W. In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype. Immunology 2004, 113:491-498.
21. Goodridge H.S., Marshall F.A., Else K.J., Houston K.M., Egan C., Al-Riyami L., Liew F.Y., Harnett W., Harnett M.M. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J. Immunol. 2005, 174:284-293.
22. Harnett W., Harnett M.M. Helminth-derived immunomodulators: can understanding the worm produce the pill?. Nat. Rev. Immunol. 2010, 10:278-284.
23. Havaux X., Zeine A., Dits A., Denis O. A new mouse model of lung allergy induced by the spores of Alternaria alternata and Cladosporium herbarum molds. Clin. Exp. Immunol. 2005, 139:179-188.
24. Hellings P.W., Kasran A., Liu Z., Vandekerckhove P., Wuyts A., Overbergh L., Mathieu C., Ceuppens J.L. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 2003, 28:42-50.
25. Holgate S.T. The epidemic of allergy and asthma. Nature 1999, 402:B2-B4.
26. Houston K., Wilson E.H., Eyres L., Brombacher F., Harnett M.M., Alexander J., Harnett W. The presence of phosphorylcholine on a filarial nematode protein influences the IgG subclass response to a molecule and by a mechanism dependent on IL-10. Infect Immun. 2000, 68:5466-5468.
27. Ito K., Herbert C., Siegle J.S., Vuppusetty C., Hansbro N., Thomas P.S., Foster P.S., Barnes P.J., Kumar R.K. Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am. J. Respir. Cell Mol. Biol. 2008, 39:543-550.
28. Iwakura Y., Ishigame H., Saijo S., Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011, 34:149-162.
29. Jager A., Kuchroo V.K. Effector and regulatory T cell subsets in autoimmunity and tissue inflammation. Scand. J. Immunol. 2010, 72:173-184.
30. Jeannin P., Lecoanet S., Delneste Y., Gauchat J.F., Bonnefoy J.Y. IgE versus IgG4 production can be differentially regulated by IL-10. J. Immunol. 1998, 160:3555-3561.
31. Kawaguchi M., Adachi M., Oda N., Kokubu F., Huang S.K. IL-17 cytokine family. J. Allergy Clin. Immunol. 2004, 114:1265-1273.
32. Kolls J.K., Kanaly S.T., Ramsay A.J. Interleukin-17: an emerging role in lung inflammation. Am. J. Respir. Cell Mol. Biol. 2003, 28:9-11.
33. Kolls J.K., Linden A. Interleukin 17 family members and inflammation. Immunity 2004, 21:467-476.
34. Lajoie S., KLewkowich I.P., Suzuki Y., Clark J.R., Sproles A.A., Dienger K., Biudelsky A.L., Wills-Karp M. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 2010, 11:928-935.
35. Lal R.B., Paranjape R.S., Briles D.E., Nutman T.B., Ottesen E.A. Circulating parasite antigen(s) in lymphatic filariasis - use of monoclonal-antibodies to phosphocholine for immunodiagnosis. J. Immunol. 1987, 138:3454-3460.
36. Leonardi-Bee J., Pritchard D., Britton J. Asthma and current intestinal parasite infection: systematic review and meta-analysis. Am. J. Respir. Crit. Care Med. 2006, 174:514-523.
37. Lima C., Perini A., Garcia M.L., Martins M.A., Teixeira M.M., Macedo M.S. Eosinophilic inflammation and airway hyper-responsiveness are profoundly inhibited by a helminth (Ascaris suum) extract in a murine model of asthma. Clin. Exp. Allergy 2002, 32:1659-1666.
38. Linden A. Rationale for targeting interleukin 17 in the lungs. Curr. Opin. Investig. Drugs 2003, 4:1304-1312.
39. Ma C.S., Chew G.Y., Simpson N., Priyadarshi A., Wong M., Grimbacher B., Fulcher D.A., Tangye S.G., Cook M.C. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 2008, 205:1551-1557.
40. Marshall F.A., Grierson A.M., Garside P., Harnett W., Harnett M.M. ES-62, an immunomodulator secreted by filarial nematodes, suppresses clonal expansion and modifies effector function of heterologous antigen-specific T cells in vivo. J. Immunol. 2005, 175:5817-5826.
41. McInnes I.B., Leung B.P., Harnett M., Gracie J.A., Liew F.Y., Harnett W. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J. Immunol. 2003, 171:2127-2133.
42. McKay A., Leung B.P., McInnes I.B., Thomson N.C., Liew F.Y. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J. Immunol. 2004, 172:2903-2908.
43. McSorley H.J., O'Gorman M.T., Blair N., Sutherland T.E., Filbey K.J., Maizels R.M. Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus. Eur. J. Immunol. 2012, 42:2667-2682.
44. Melendez A.J., Harnett M.M., Pushparaj P.N., Wong W.S., Tay H.K., McSharry C.P., Harnett W. Inhibition of FcepsilonRI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat. Med. 2007, 13:1375-1381.
45. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., Kanno Y., Spalding C., Elloumi H.Z., Paulson M.L., Davis J., Hsu A., Asher A.I., O'Shea J., Holland S.M., Paul W.E., Douek D.C. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
46. Morton A.M., McManus B., Garside P., Mowat A.M., Harnett M.M. Inverse Rap1 and phospho-ERK expression discriminate the maintenance phase of tolerance and priming of antigen-specific CD4+ T cells in vitro and in vivo. J. Immunol. 2007, 179:8026-8034.
47. Munthe-Kaas M.C., Carlsen K.H., Haland G., Devulapalli C.S., Gervin K., Egeland T., Carlsen K.L., Undlien D. T cell-specific T-box transcription factor haplotype is associated with allergic asthma in children. J. Allergy Clin. Immunol. 2008, 121:51-56.
48. Murdock B.J., Falkowski N.R., Shreiner A.B., Sadighi Akha A.A., McDonald R.A., White E.S., Toews G.B., Huffnagle G.B. Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia. Infect. Immun. 2012, 80:1424-1436.
49. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.
50. Pichavant M., Goya S., Meyer E.H., Johnston R.A., Kim H.Y., Matangkasombut P., Zhu M., Iwakura Y., Savage P.B., DeKruyff R.H., Shore S.A., Umetsu D.T. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med. 2008, 205:385-393.
51. Pineda M.A., McGrath M.A., Smith P.C., Al-Riyami L., Rzepecka J., Gracie J.A., Harnett W., Harnett M.M. The parasitic helminth product ES-62 suppresses pathogenesis in CIA by targeting of the IL-17-producing cellular network at multiple sites. Arthritis Rheum. 2012, 64:3168-3178.
52. Raby B.A., Hwang E.S., Van Steen K., Tantisira K., Peng S., Litonjua A., Lazarus R., Giallourakis C., Rioux J.D., Sparrow D., Silverman E.K., Glimcher L.H., Weiss S.T. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2006, 173:64-70.
53. Schnoeller C., Rausch S., Pillai S., Avagyan A., Wittig B.M., Loddenkemper C., Hamann A., Hamelmann E., Lucius R., Hartmann S. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J. Immunol. 2008, 180:4265-4272.
54. Schnyder-Candrian S., Togbe D., Couillin I., Mercier I., Brombacher F., Quesniaux V., Fossiez F., Ryffel B., Schnyder B. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 2006, 203:2715-2725.
55. Shreiner A.B., Murdock B.J., Sadighi Akha A.A., Falkowski N.R., Christensen P.J., White E.S., Hogaboam C.M., Huffnagle G.B. Repeated exposure to Aspergillus fumigatus conidia results in CD4+ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1/Th2/Th17 microenvironment that requires interleukin-4 (IL-4) and IL-10. Infect. Immun. 2012, 80:388-397.
56. Strachan D.P. Hay fever, hygiene, and household size. BMJ (Clinical Research ed.) 1989, 299:1259-1260.
57. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science (New York, NY) 2002, 295:338-342.
58. Traves S.L., Donnelly L.E. Th17 cells in airway diseases. Curr. Mol. Med. 2008, 8:416-426.
59. Umetsu D.T., McIntire J.J., Akbari O., Macaubas C., DeKruyff R.H. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 2002, 3:715-720.
60. Wang Y.H., Liu Y.J. The IL-17 cytokine family and their role in allergic inflammation. Curr. Opin. Immunol. 2008, 20:697-702.
61. Wang Y.H., Voo K.S., Liu B., Chen C.Y., Uygungil B., Spoede W., Bernstein J.A., Huston D.P., Liu Y.J. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 2010, 207:2479-2491.
62. Whelan M., Harnett M.M., Houston K.M., Patel V., Harnett W., Rigley K.P. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J. Immunol. 2000, 164:6453-6460.
63. Wilson E.H., Deehan M.R., Katz E., Brown K.S., Houston K.M., O'Grady J., Harnett M.M., Harnett W. Hyporesponsiveness of murine B lymphocytes exposed to the filarial nematode secreted product ES-62 in vivo. Immunology 2003, 109:238-245.
64. Wilson M.S., Taylor M.D., Balic A., Finney C.A., Lamb J.R., Maizels R.M. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J. Exp. Med. 2005, 202:1199-1212.
65. Yang M., Kumar R.K., Foster P.S. Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-gamma and TLR4/MyD88 pathways. J. Immunol. 2009, 182:5107-5115.
66. Yang M., Kumar R.K., Hansbro P.M., Foster P.S. Emerging roles of pulmonary macrophages in driving the development of severe asthma. J. Leukoc. Biol. 2012, 91:557-569.